Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative

Mikkael A. Sekeres, Stephanie A. Stowell, Carolyn A. Berry, William M. Mencia, Ja Neen N. Dancy

Research output: Contribution to journalArticle

Abstract

Challenges exist in the diagnosis and treatment of myelodysplastic syndromes (MDS). Early clinical presentation can be subtle, accurate classification requires careful consideration of pathologic features and cytogenetics, and treatment options vary based on disease severity. A performance improvement (PI) continuing medical education initiative was developed to strengthen physician practices and improve the quality of MDS patient care. Physician participants demonstrated significant gains in the diagnosis and classification of MDS and in the documentation of erythropoietin levels. Improvements related to patient communication and disease education were also observed and support the overall efficacy and value of PI in MDS patient care.

Original languageEnglish (US)
Pages (from-to)422-426
Number of pages5
JournalLeukemia Research
Volume37
Issue number4
DOIs
StatePublished - Apr 2013

Keywords

  • Continuing medical education
  • Myelodysplastic syndromes
  • Performance improvement
  • Quality patient care

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative'. Together they form a unique fingerprint.

  • Cite this